Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Baird Maintains Outperform on Acuity Brands, Raises Price Target to $190

Baird Maintains Outperform on Acuity Brands, Raises Price Target to $190

Baird analyst Timothy Wojs maintains Acuity Brands (NYSE:AYI) with a Outperform and raises the price target from $188 to $190.

byBenzinga Newsdesk

July 1, 2022

1 minute read

Baird analyst Timothy Wojs maintains Acuity Brands (NYSE:AYI) with a Outperform and raises the price target from $188 to $190.

Robinhood Q3 Earnings: EPS Beat, Revenue Up 29%, MAUs Fall 16% And More

By Adam Eckert

November 7, 5:57 PM

Robinhood Markets Inc (NASDAQ: HOOD) shares are trading lower in Tuesday's after-hours session following the company's third-quarter financial results.

HOOD

$100 Invested In Cassava Sciences 5 Years Ago Would Be Worth This Much Today

By Benzinga Insights

January 18, 4:32 PM

Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 27.31% on an annualized basis…

SAVA

Wells Fargo Maintains Equal-Weight on RLJ Lodging, Lowers Price Target to $13.5

By Benzinga Newsdesk

August 29, 7:04 AM

Wells Fargo analyst Dori Kesten maintains RLJ Lodging (NYSE:RLJ) with a Equal-Weight and lowers the price target from $15 to $13.5.

RLJ

Analyst Ratings

What 8 Analyst Ratings Have To Say About Globus Medical

By Benzinga Insights

March 28, 1:00 PM

Analysts have provided the following ratings for Globus Medical (NYSE:GMED) within the last quarter: Bullish Somewhat Bullish Indifferent…

GMED

Baird Maintains Outperform on Acuity Brands, Raises Price Target to $190

Related Posts

Robinhood Q3 Earnings: EPS Beat, Revenue Up 29%, MAUs Fall 16% And More

$100 Invested In Cassava Sciences 5 Years Ago Would Be Worth This Much Today

Wells Fargo Maintains Equal-Weight on RLJ Lodging, Lowers Price Target to $13.5

What 8 Analyst Ratings Have To Say About Globus Medical